Syneos Health

About:

Syneos Health, the only fully integrated end-to-end clinical and commercial solution organization.

Website: https://www.syneoshealth.com/

Twitter/X: syneoshealth

Top Investors: Adams Street Partners, Advent International, Veritas Capital, Patient Square Capital, THL

Description:

Syneos Health® (Nasdaq:SYNH) is the only fully integrated biopharmaceutical solutions organization. The Company, including a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), is purpose-built to accelerate customer performance to address modern market realities. We bring together approximately 24,000 clinical and commercial minds with the ability to support customers in more than 110 countries. Together we share insights, use the latest technologies and apply advanced business practices to speed our customers’ delivery of important therapies to patients.

Total Funding Amount:

$525M

Estimated Revenue Range:

$1B to $10B

Headquarters Location:

Morrisville, North Carolina, United States

Founded Date:

1985-01-01

Founders:

Candace Kendle, Meg Alexander

Number of Employees:

1001-5000

Last Funding Date:

2023-09-28

IPO Status:

Delisted

© 2025 bioDAO.ai